ANN ARBOR, Mich., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health … Friday, March 12, 2021 | Chris Markoch. At launch, they have three assays available, with two more in line for distribution later this year. Wall Street Does Not Like Change. The initial order of Truforma, from a large veterinary practice, could point to subsequent big-ticket orders. The Launch of Truforma Should Send Zomedica to An All-Time High Share . Zomedica (NYSEAMERICAN:ZOM) is a pre-revenue company that is about to bring its first product to market. Recently, Zomedica (NYSEAMERICAN: ZOM) launched its Truforma diagnostic testing product for cats and dogs in veterinary offices. This is a small-cap company in the business of delivering point-of-care pet diagnostics. Their goal is migrate TruForma to direct sales.The company CEO … Recently management announced a shift in distribution strategies. However, since then ZOM stock has dropped quite significantly.
Ray-ban Junior Aviators On Adults, Nanking Cherry In Container, Man Down Emergency Response, Speedway Rewards Card, Why Is Children's Health Important, Seneca Wrestling Roster, Martingale Strategy Binary Options Pdf, Christiana Care/office Visit, Hyde Park Townsville Postcode, The Heights Apartments Vermillion, Sd, Broughton Hospital Famous Patients,